Original language | English |
---|---|
Pages (from-to) | E789 |
Journal | HemaSphere |
Volume | 6 |
Issue number | 11 |
DOIs | |
Publication status | Published - 25 Nov 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: HemaSphere, Vol. 6, No. 11, 25.11.2022, p. E789.
Research output: Contribution to journal › Letter › Academic › peer-review
TY - JOUR
T1 - Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine
T2 - An EPICOVIDEHA Report
AU - Salmanton-García, Jon
AU - Marchesi, Francesco
AU - Glenthøj, Andreas
AU - Bilgin, Yavuz M.
AU - van Praet, Jens
AU - Dávila-Valls, Julio
AU - Martín-Pérez, Sonia
AU - Labrador, Jorge
AU - van Doesum, Jaap
AU - Falces-Romero, Iker
AU - Farina, Francesca
AU - Schönlein, Martin
AU - Chanut, Mathilde
AU - Petzer, Verena
AU - Espigado, Ildefonso
AU - Dargenio, Michelina
AU - Aujayeb, Avinash
AU - Sili, Uluhan
AU - Serrano, Laura
AU - Pinczés, L. szló Imre
AU - de Jonge, Nick
AU - Soto-Silva, Andrés
AU - Buquicchio, Caterina
AU - Prezioso, Lucia
AU - Marchetti, Monia
AU - Meers, Stef
AU - Busca, Alessandro
AU - Corradini, Paolo
AU - Hoenigl, Martin
AU - Koehler, Philipp
AU - Rahimli, Laman
AU - Çolak, G. kçe Melis
AU - Arellano, Elena
AU - Wolf, Dominik
AU - Gräfe, Stefanie
AU - Ammatuna, Emanuele
AU - Berg Venemyr, Caroline
AU - Cornely, Oliver A.
AU - Pagano, Livio
N1 - Funding Information: EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223). The funder of the study had no role in study design, data analysis, interpretation, or writing of the report. All authors had full access to the data and had final responsibility for the decision to submit for publication.
PY - 2022/11/25
Y1 - 2022/11/25
UR - http://www.scopus.com/inward/record.url?scp=85143836045&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/HS9.0000000000000789
DO - https://doi.org/10.1097/HS9.0000000000000789
M3 - Letter
C2 - 36310756
SN - 2572-9241
VL - 6
SP - E789
JO - HemaSphere
JF - HemaSphere
IS - 11
ER -